NCT06415695

Evaluating the Feasibility of a Dietary Weight Loss Program to Overcome Obesity and Its Comorbidity Among Arab Populations

Name: Clinical Trial NCT06415695
Creator: Asma Yahya
Keywords: Overweight and Obesity, Education sessions, behavioral, clinical trial, Saudi Arabia

Evaluating the Feasibility of a Dietary Weight Loss Program to Overcome Obesity and Its Comorbidity Among Arab Populations: Pilot Study

Asma Yahya·ClinicalTrials.gov·behavioralNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Overweight and Obesity
Drug/Device/Intervention: Education sessions
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Asma Yahya
Funder: University of Illinois at Urbana-Champaign
Location: Makkah, Saudi Arabia

Timeline & enrollment

Phase: N/A
Start date: Jun 10, 2024
End date: Oct 01, 2024
Enrollment: 20 participants

Primary outcome

Program feasibility and acceptability

Summary

This study aims to develop and test a culturally tailored online weight loss program for the Saudi population. Building upon the success of a previous program in the United States, the research team will adapt educational materials and conduct a pilot study to assess the feasibility and initial outcomes of the program among Arab participants. The study seeks to answer questions about the program's acceptability, effectiveness, and scalability, with the ultimate goal of combating obesity and its related health issues in Saudi Arabia.

ICD-10 classifications

ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06415695
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06415695 through Pure Global AI's free database. This phase not specified trial is sponsored by Asma Yahya and is currently Not yet recruiting. The study focuses on Overweight and Obesity. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.